273 related articles for article (PubMed ID: 35452357)
1. Self-Reported adverse events among Chinese healthcare workers immunized with COVID-19 vaccines composed of inactivated SARS-CoV-2.
Cheng Y; Li T; Zheng Y; Xu B; Bi Y; Hu Y; Zhou YH
Hum Vaccin Immunother; 2022 Nov; 18(5):2064134. PubMed ID: 35452357
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
3. Attitudes towards and safety of the SARS-CoV-2 inactivated vaccines in 188 patients with systemic lupus erythematosus: a post-vaccination cross-sectional survey.
Tang Q; Li F; Tian J; Kang J; He J
Clin Exp Med; 2023 Jun; 23(2):457-463. PubMed ID: 35612692
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccination in patients with primary immunodeficiencies: an international survey on patient vaccine hesitancy and self-reported adverse events.
Pergent M; Haerynck F; Hoste L; Gardulf A
Front Immunol; 2023; 14():1166198. PubMed ID: 37143673
[TBL] [Abstract][Full Text] [Related]
5. Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China.
Zhang S; Li J; Xu R; Chen Q; Sun G; Lin Y; Cao Y; Chen Y; Geng C; Teng Y; Nie J; Li X; Xu G; Liu X; Jin F; Fan Z; Luo T; Liu H; Wang FS; Jiang Z
JMIR Public Health Surveill; 2023 Dec; 9():e46009. PubMed ID: 38060302
[TBL] [Abstract][Full Text] [Related]
6. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
Zhang Y; Zeng G; Pan H; Li C; Hu Y; Chu K; Han W; Chen Z; Tang R; Yin W; Chen X; Hu Y; Liu X; Jiang C; Li J; Yang M; Song Y; Wang X; Gao Q; Zhu F
Lancet Infect Dis; 2021 Feb; 21(2):181-192. PubMed ID: 33217362
[TBL] [Abstract][Full Text] [Related]
7. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
[TBL] [Abstract][Full Text] [Related]
8. Sex and gender differences in adverse events following influenza and COVID-19 vaccination.
Yin A; Wang N; Shea PJ; Rosser EN; Kuo H; Shapiro JR; Fenstermacher KZJ; Pekosz A; Rothman RE; Klein SL; Morgan R
Biol Sex Differ; 2024 Jun; 15(1):50. PubMed ID: 38890702
[TBL] [Abstract][Full Text] [Related]
9. Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in China.
Zhang MX; Zhang TT; Shi GF; Cheng FM; Zheng YM; Tung TH; Chen HX
Expert Rev Vaccines; 2021 Jul; 20(7):891-898. PubMed ID: 33929930
[No Abstract] [Full Text] [Related]
10. [Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].
Özgür D; Tütüncü EE
Mikrobiyol Bul; 2022 Jan; 56(1):36-48. PubMed ID: 35088958
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of inactivated COVID-19 vaccine in health care workers.
Benjamanukul S; Traiyan S; Yorsaeng R; Vichaiwattana P; Sudhinaraset N; Wanlapakorn N; Poovorawan Y
J Med Virol; 2022 Apr; 94(4):1442-1449. PubMed ID: 34783049
[TBL] [Abstract][Full Text] [Related]
12. [The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].
Topkaya AE; Keskin AÜ; Dalan AB; Çıragil P
Mikrobiyol Bul; 2022 Jan; 56(1):139-142. PubMed ID: 35088968
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 vaccination coverage among healthcare workers in obstetrics and gynecology during the first three months of vaccination campaign: a cross-sectional study in Jiangsu province, China.
Zheng Y; Shen P; Xu B; Chen Y; Luo Y; Dai Y; Hu Y; Zhou YH
Hum Vaccin Immunother; 2021 Dec; 17(12):4946-4953. PubMed ID: 34802373
[TBL] [Abstract][Full Text] [Related]
14. Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national survey study.
Amer SA; Al-Zahrani A; Imam EA; Ishteiwy EM; Djelleb IF; Abdullh LR; Ballaj D; Amer YA; El-Sokkary RH; Elshabrawy AM; Eskander G; Shah J; Raza ML; ALsafa AMAA; Ali HT; Fawzy HM
Sci Rep; 2024 Feb; 14(1):4785. PubMed ID: 38413637
[TBL] [Abstract][Full Text] [Related]
15. The Actual Status of Hospitals as COVID-19 Vaccination Clinics in China and Safety Monitoring of Inactivated Vaccine: A Cross-Sectional Study.
Huang J; Zhang MQ; Huang MZ; Lin GM
Disaster Med Public Health Prep; 2022 Aug; 17():e256. PubMed ID: 36017705
[TBL] [Abstract][Full Text] [Related]
16. Adverse effect investigation using application software after vaccination against SARS-CoV-2 for healthcare workers.
Yamazaki S; Watanabe K; Okuda Y; Urushihara M; Koshikawa H; Chiba H; Yahaba M; Taniguchi T; Nakada TA; Nakajima H; Ishii I; Igari H
J Infect Chemother; 2022 Jun; 28(6):791-796. PubMed ID: 35248497
[TBL] [Abstract][Full Text] [Related]
17. Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine.
Raw RK; Rees J; Kelly CA; Wroe C; Chadwick DR
Vaccine; 2022 Jan; 40(3):418-423. PubMed ID: 34895935
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of two coronavirus disease 2019 (COVID-19) vaccines (viral vector and inactivated viral vaccine) against severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in a cohort of healthcare workers.
Marra AR; Miraglia JL; Malheiros DT; Guozhang Y; Teich VD; da Silva Victor E; Pinho JRR; Cypriano A; Vieira LW; Polonio M; Ornelas RH; de Oliveira SM; Borges Junior FA; Shibata ARO; Schettino GPP; de Oliveira KG; Ferraz Santana RA; de Mello Malta F; Amgarten D; Boechat AL; Trecenti NMZ; Kobayashi T; Salinas JL; Edmond MB; Rizzo LV
Infect Control Hosp Epidemiol; 2023 Jan; 44(1):75-81. PubMed ID: 35351217
[TBL] [Abstract][Full Text] [Related]
19. Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine.
Cucunawangsih C; Wijaya RS; Lugito NPH; Suriapranata I
Int J Infect Dis; 2022 May; 118():116-118. PubMed ID: 35192955
[TBL] [Abstract][Full Text] [Related]
20. Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers.
Soysal A; Gönüllü E; Karabayır N; Alan S; Atıcı S; Yıldız İ; Engin H; Çivilibal M; Karaböcüoğlu M
Hum Vaccin Immunother; 2021 Nov; 17(11):3876-3880. PubMed ID: 34324409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
